# Scotts Miracle-Gro Co: overview

SMG · NYSE · CIK 825542 · [Materials](/sectors/materials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/smg.md) · [Financials](/companies/smg/financials.md) · [Filings](/companies/smg/filings.md) · [Insiders](/companies/smg/insiders.md)

Latest reported revenue: [$1.17bn](/filings/0000825542-26-000041.md) for Q3 FY2026, three months to 2026-06-27, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000825542-26-000041).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [415 d](/filings/0000825542-25-000022.md) | [367](/filings/0000825542-26-000008.md) | [1,390](/filings/0000825542-26-000024.md) | [1,159](/filings/0000825542-26-000041.md) | [497 d](/filings/0000825542-25-000022.md) | [354](/filings/0000825542-26-000008.md) | [1,460](/filings/0000825542-26-000024.md) | [1,172](/filings/0000825542-26-000041.md) |
| Gross margin | % | [(7.1%) d](/filings/0000825542-25-000022.md) | [24.1%](/filings/0000825542-26-000008.md) | [39.0%](/filings/0000825542-26-000024.md) | [32.1%](/filings/0000825542-26-000041.md) | [8.2% d](/filings/0000825542-25-000022.md) | [25.0%](/filings/0000825542-26-000008.md) | [41.8%](/filings/0000825542-26-000024.md) | [31.2%](/filings/0000825542-26-000041.md) |
| Operating margin | % | [(52.1%) d](/filings/0000825542-25-000022.md) | [(12.5%)](/filings/0000825542-26-000008.md) | [25.2%](/filings/0000825542-26-000024.md) | [19.1%](/filings/0000825542-26-000041.md) | [(33.6%) d](/filings/0000825542-25-000022.md) | [(6.2%)](/filings/0000825542-26-000008.md) | [27.5%](/filings/0000825542-26-000024.md) | [14.5%](/filings/0000825542-26-000041.md) |
| Net margin | % | [(58.8%) d](/filings/0000825542-25-000022.md) | [(19.0%)](/filings/0000825542-26-000008.md) | [15.7%](/filings/0000825542-26-000024.md) | [12.9%](/filings/0000825542-26-000041.md) | [(30.5%) d](/filings/0000825542-25-000022.md) | [(35.3%)](/filings/0000825542-26-000008.md) | [16.3%](/filings/0000825542-26-000024.md) | [9.6%](/filings/0000825542-26-000041.md) |
| Diluted EPS | $ per share | not reported | [(1.21)](/filings/0000825542-26-000008.md) | [3.72](/filings/0000825542-26-000024.md) | [2.54](/filings/0000825542-26-000041.md) | not reported | [(2.16)](/filings/0000825542-26-000008.md) | [4.04](/filings/0000825542-26-000024.md) | [1.90](/filings/0000825542-26-000041.md) |
| Free cash flow | $m | [102 d](/filings/0000825542-25-000022.md) | [(475)](/filings/0000825542-26-000008.md) | [180 d](/filings/0000825542-26-000024.md) | [438 d](/filings/0000825542-26-000041.md) | [131 d](/filings/0000825542-25-000022.md) | [(390)](/filings/0000825542-26-000008.md) | [201 d](/filings/0000825542-26-000024.md) | [321 d](/filings/0000825542-26-000041.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-09-30) | FY2022 (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,925](/filings/0001546380-23-000037.md) | [3,924](/filings/0001546380-24-000043.md) | [3,551](/filings/0000825542-25-000022.md) | [3,553](/filings/0000825542-25-000022.md) | [3,413](/filings/0000825542-25-000022.md) |
| Gross margin | % | [29.8%](/filings/0001546380-23-000037.md) | [22.2%](/filings/0001546380-24-000043.md) | [18.5%](/filings/0000825542-25-000022.md) | [23.9%](/filings/0000825542-25-000022.md) | [30.6%](/filings/0000825542-25-000022.md) |
| Operating margin | % | [14.7%](/filings/0001546380-23-000037.md) | [(11.1%)](/filings/0001546380-24-000043.md) | [(4.9%)](/filings/0000825542-25-000022.md) | [5.9%](/filings/0000825542-25-000022.md) | [10.5%](/filings/0000825542-25-000022.md) |
| Net margin | % | [10.4%](/filings/0001546380-23-000037.md) | [(11.1%)](/filings/0001546380-24-000043.md) | [(10.7%)](/filings/0000825542-25-000022.md) | [(1.0%)](/filings/0000825542-25-000022.md) | [4.3%](/filings/0000825542-25-000022.md) |
| Diluted EPS | $ per share | [8.96](/filings/0001546380-23-000037.md) | [(7.88)](/filings/0001546380-24-000043.md) | [(6.79)](/filings/0000825542-25-000022.md) | [(0.61)](/filings/0000825542-25-000022.md) | [2.47](/filings/0000825542-25-000022.md) |
| Free cash flow | $m | [165](/filings/0001546380-23-000037.md) | [(243)](/filings/0001546380-24-000043.md) | [438](/filings/0000825542-25-000022.md) | [584](/filings/0000825542-25-000022.md) | [274](/filings/0000825542-25-000022.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/smg/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $303.8m | 4,460,250 |  | Added +15,594 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $279.0m | 4,096,622 |  | Added +1,955,427 |
| [EARNEST PARTNERS LLC](/funds/1102578.md) | 2026-06-30 | $247.3m | 3,630,876 |  | Added +231,228 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $165.1m | 2,424,539 |  | Reduced −78,601 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $134.8m | 1,978,656 |  | Added +19,938 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $109.1m | 1,601,610 |  | Added +82,688 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $107.9m | 1,584,281 |  | Added +173,441 |
| [ARIEL INVESTMENTS, LLC](/funds/936753.md) | 2026-06-30 | $96.1m | 1,410,981 |  | Added +448,339 |
| [BRANDES INVESTMENT PARTNERS, LP](/funds/1015079.md) | 2026-06-30 | $91.0m | 1,335,820 |  | Added +527,013 |
| [Quantinno Capital Management LP](/funds/1759654.md) | 2026-06-30 | $87.0m | 1,278,061 |  | Added +1,060,092 |

## Recent filings

[All 3,726 filings](/companies/smg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 16:06 ET | [8-K](/filings/0000825542-26-000058.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000825542-26-000058 |
| 2026-09-25 | 16:02 ET | [8-K/A](/filings/0000825542-26-000054.md) | 5.02 Departure or appointment of officers or directors | 0000825542-26-000054 |
| 2026-09-15 | 08:33 ET | [8-K](/filings/0000825542-26-000050.md) | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000825542-26-000050 |
| 2026-09-11 | 16:03 ET | [8-K](/filings/0000825542-26-000047.md) | 5.02 Departure or appointment of officers or directors | 0000825542-26-000047 |
| 2026-09-03 | 16:06 ET | [8-K](/filings/0000825542-26-000045.md) | 5.02 Departure or appointment of officers or directors | 0000825542-26-000045 |
| 2026-08-27 | 08:07 ET | [8-K](/filings/0000825542-26-000043.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000825542-26-000043 |
| 2026-08-05 | 16:07 ET | [10-Q](/filings/0000825542-26-000041.md) | Quarterly report, period 2026-06-27 | 0000825542-26-000041 |
| 2026-07-29 | 07:36 ET | [8-K](/filings/0000825542-26-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000825542-26-000036 |
| 2026-07-01 | 16:05 ET | [8-K](/filings/0000825542-26-000032.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000825542-26-000032 |
| 2026-05-06 | 16:07 ET | [10-Q](/filings/0000825542-26-000024.md) | Quarterly report, period 2026-03-28 | 0000825542-26-000024 |

## Latest annual report

[Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0000825542-25-000022.md), filed Nov 25, 2025.

## Forecast league

Q4 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/2467843a-c83c-4bd7-bd0d-b8160250b8a2)

## About the filer

- CIK: 825542
- Tickers: SMG
- Exchange: NYSE
- SIC code: 2870 Agricultural Chemicals
- State of incorporation: OH
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:19 ET. No prices; not investment advice.